JB Pharma open to more buys to grow branded biz share

JB Chemicals & Pharmaceuticals (JB Pharma), controlled by US private equity firm KKR, is evaluating assets for acquisitions to strengthen its market share in the domestic branded formulation business. CEO Nikhil Chopra said the assets should be at the right valuation and have synergy with the existing business, with a payback period of seven to eight years.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/layZUTW
via IFTTT